Preclinical tolerance and pharmacokinetic assessment of MU-gold, a novel chemotherapeutic agent, in laboratory dogs

Veterinary Therapeutics

Volumn 4, Issue 1, 2003, Pages

  Higginbotham, Mary ^a   Henry, Carolyn ^a   Katti, Kattesh ^a   Casteel, Stan ^a   Dowling, Patricia ^a   Pillarsetty, Nagavarakishore ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANIS FAMILIARIS; RODENTIA;

EID: 79251470136     PISSN: 15283593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Chu E, DeVita Jr VT: Principles of cancer management: Chemotherapy, in DeVita Jr VT, Hellman S, Rosenberg SA (eds): Cancer Principles and Practice of Oncology, ed 6. Philadelphia, Lippincott, Williams, & Wilkins, 2001, pp 289-291.
2. American Hospital Formulary Service: 1997 Drug Handbook. Bethesda, MD, American Society of Health-System Pharmacists, 1997, pp 2318-2327.
3. Fricker SP: Medicinal chemistry and pharmacology of gold compounds. Transition Met Chem 21:377-383, 1996.
4. Berners-Price SJ, Mirabelli CK, Johnson RK, et al: In vivo antitumor activity and in vitro cytotoxic properties of bis[1,2-bis(diphenylphosphino) ethane]gold(I) chloride. Cancer Res 46:5486-5493, 1986.
5. Simon TM, Kunishima DH, Vibert GJ, Lorber A: Screening trial with the coordinated gold compound Auranofin using mouse lymphocytic leukemia P388. Cancer Res 41:94-97, 1981.
6. Mirabelli CK, Johnson RK, Sung CM, et al: Evaluation of the in vivo antitumor activity and in vitro cytotoxic properties of Auranofin, a coordinated gold compound, in murine tumor models. Cancer Res 45:32-39, 1985.
7. Hoke GD, Macia RA, Meunier PC, et al: In vivo and in vitro cardiotoxicity of a gold-containing antineoplastic drug candidate in the rabbit. Toxicol Appl Pharmacol 100:293-306, 1989.
8. Ni Dhubhghaill OM, Sadler PJ: Gold complexes in cancer chemotherapy: A review, in Keppler BK (ed): Metal Complexes in Cancer Chemotherapy. Weinheim, VCH Publishers, 1993, pp 221-248.
9. Shaw III CF: Gold, in Fricker SP (ed): Metal Compounds in Cancer Therapy. London, Chapman and Hall, 1994, pp 46-64.
10. Fadok VA, Janney EH: Thrombocytopenia and hemorrhage associated with gold salt for bullous pemphigoid in a dog. JAVMA 181(3):261-262, 1982.
11. Guo Z, Sadler PJ: Metals in medicine. Angew Chem Int Ed 38:1512-1531, 1999.
12. Frazier DL, Hahn KA: Commonly used drugs, in Hahn KA, Richardson RC (eds): Cancer Chemotherapy: A Veterinary Handbook. Baltimore, Williams & Wilkins, 1995, pp 92-93.
13. Berning DE, Katti KV, Volkert WA, et al: 198-Au labeled hydroxymethyl phosphines as models for potential therapeutic pharmaceuticals. Nucl Med Biol 25:577-583, 1998.
14. Pillarsetty N, Katti KK, Hoffman TJ, et al: In vitro and in vivo antitumor properties of tetrakis ([trishydroxymethyl] phosphine) gold(I) chloride. J Med Chem, in press.
15. Kastan MB, Skapek SX: Molecular biology of cancer: The cell cycle, in DeVita VT, Hellman S, Rosenberg SA (eds): Cancer Principles and Practice of Oncology, ed 6. Philadelphia, Lippincott, Williams, & Wilkins, 2001, 91-109.
16. Katti KV, Gali H, Berning DE, et al: Design and development of functionalized water-soluble phosphines: Catalytic and biomedical implications. Acc Chem Res 32:9-17, 1999.
17. Dietz AA, Rubinstein HM: Serum gold. I. Estimation by atomic absorption spectroscopy. Ann Rheum Dis 32(2):124-127, 1973.
18. Lorber A, Cohen RL, Chancy CC, et al: Gold determinations in biological fluids by atomic absorption spectrophotometer: Application to chrysotherapy in rheumatoid arthritis patients. Arthritis Rheum 11:170-177, 1968.
19. Rooney TW, Lorber A, Veng-Pedersen P, et al: Gold pharmacokinetics in breast milk and serum of a lactating woman. J Rheumatol 14(6):1120-1122, 1987.
20. Vail DM, MacEwen GE: Spontaneously occurring tumors of companion animals as models for human cancer. Cancer Invest 18(8):781-792, 2000.
21. MacEwen GE: Spontaneous tumors in dogs and cats: Models for the study of cancer biology and treatment. Cancer Metastasis Rev 9:125-136, 1990.
22. Ogilvie GK, Straw RC, Jameson VJ, et al: Evaluation of single-agent chemotherapy for treatment of clinically evident osteosarcoma metastases in dogs: 45 cases (1987-1991). JAVMA 202(2):304-306, 1993.